nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—CYP3A4—breast cancer	0.186	0.546	CbGaD
Ergonovine—ABCB1—breast cancer	0.155	0.454	CbGaD
Ergonovine—ABCB1—Toremifene—breast cancer	0.043	0.0909	CbGbCtD
Ergonovine—CYP3A4—Exemestane—breast cancer	0.0372	0.0786	CbGbCtD
Ergonovine—CYP3A4—Letrozole—breast cancer	0.0316	0.0668	CbGbCtD
Ergonovine—ABCB1—Lapatinib—breast cancer	0.0314	0.0663	CbGbCtD
Ergonovine—CYP3A4—Anastrozole—breast cancer	0.0282	0.0596	CbGbCtD
Ergonovine—CYP3A4—Toremifene—breast cancer	0.0258	0.0545	CbGbCtD
Ergonovine—CYP3A4—Fulvestrant—breast cancer	0.024	0.0506	CbGbCtD
Ergonovine—CYP3A4—Thiotepa—breast cancer	0.0214	0.0451	CbGbCtD
Ergonovine—CYP3A4—Ixabepilone—breast cancer	0.0195	0.0413	CbGbCtD
Ergonovine—CYP3A4—Lapatinib—breast cancer	0.0188	0.0397	CbGbCtD
Ergonovine—ABCB1—Vinorelbine—breast cancer	0.0174	0.0368	CbGbCtD
Ergonovine—ABCB1—Tamoxifen—breast cancer	0.0157	0.0332	CbGbCtD
Ergonovine—ABCB1—Mitoxantrone—breast cancer	0.0153	0.0324	CbGbCtD
Ergonovine—CYP3A4—Raloxifene—breast cancer	0.0142	0.0301	CbGbCtD
Ergonovine—ABCB1—Gemcitabine—breast cancer	0.0135	0.0286	CbGbCtD
Ergonovine—ABCB1—Paclitaxel—breast cancer	0.0122	0.0259	CbGbCtD
Ergonovine—ABCB1—Irinotecan—breast cancer	0.0121	0.0255	CbGbCtD
Ergonovine—ABCB1—Vinblastine—breast cancer	0.0107	0.0227	CbGbCtD
Ergonovine—CYP3A4—Vinorelbine—breast cancer	0.0104	0.022	CbGbCtD
Ergonovine—CYP3A4—Tamoxifen—breast cancer	0.00941	0.0199	CbGbCtD
Ergonovine—CYP3A4—Mitoxantrone—breast cancer	0.00918	0.0194	CbGbCtD
Ergonovine—ABCB1—Docetaxel—breast cancer	0.00884	0.0187	CbGbCtD
Ergonovine—CYP3A4—Paclitaxel—breast cancer	0.00733	0.0155	CbGbCtD
Ergonovine—CYP3A4—Irinotecan—breast cancer	0.00723	0.0153	CbGbCtD
Ergonovine—ABCB1—Doxorubicin—breast cancer	0.00659	0.0139	CbGbCtD
Ergonovine—CYP3A4—Vinblastine—breast cancer	0.00643	0.0136	CbGbCtD
Ergonovine—ABCB1—Methotrexate—breast cancer	0.00638	0.0135	CbGbCtD
Ergonovine—CYP3A4—Docetaxel—breast cancer	0.0053	0.0112	CbGbCtD
Ergonovine—CYP3A4—Doxorubicin—breast cancer	0.00395	0.00835	CbGbCtD
Ergonovine—Chest pain—Melphalan—breast cancer	0.000308	0.00243	CcSEcCtD
Ergonovine—Methylergometrine—CYP3A4—breast cancer	0.000306	0.155	CrCbGaD
Ergonovine—Bradycardia—Irinotecan—breast cancer	0.000305	0.00241	CcSEcCtD
Ergonovine—Bradycardia—Mitoxantrone—breast cancer	0.000305	0.00241	CcSEcCtD
Ergonovine—Hypertension—Goserelin—breast cancer	0.000305	0.00241	CcSEcCtD
Ergonovine—Diarrhoea—Anastrozole—breast cancer	0.000302	0.00238	CcSEcCtD
Ergonovine—Diarrhoea—Letrozole—breast cancer	0.000302	0.00238	CcSEcCtD
Ergonovine—Chest pain—Goserelin—breast cancer	0.000301	0.00237	CcSEcCtD
Ergonovine—Vomiting—Ixabepilone—breast cancer	0.000298	0.00235	CcSEcCtD
Ergonovine—Nausea—Exemestane—breast cancer	0.000295	0.00233	CcSEcCtD
Ergonovine—Headache—Ixabepilone—breast cancer	0.000293	0.00232	CcSEcCtD
Ergonovine—Hyperhidrosis—Tamoxifen—breast cancer	0.000292	0.0023	CcSEcCtD
Ergonovine—Dizziness—Letrozole—breast cancer	0.000292	0.0023	CcSEcCtD
Ergonovine—Dizziness—Anastrozole—breast cancer	0.000292	0.0023	CcSEcCtD
Ergonovine—Diarrhoea—Idarubicin—breast cancer	0.000286	0.00226	CcSEcCtD
Ergonovine—Diarrhoea—Raloxifene—breast cancer	0.000286	0.00226	CcSEcCtD
Ergonovine—Vertigo—Vinorelbine—breast cancer	0.000284	0.00224	CcSEcCtD
Ergonovine—Shock—Goserelin—breast cancer	0.000284	0.00224	CcSEcCtD
Ergonovine—Vomiting—Anastrozole—breast cancer	0.00028	0.00221	CcSEcCtD
Ergonovine—Vomiting—Letrozole—breast cancer	0.00028	0.00221	CcSEcCtD
Ergonovine—Palpitations—Vinorelbine—breast cancer	0.00028	0.00221	CcSEcCtD
Ergonovine—Hyperhidrosis—Goserelin—breast cancer	0.000279	0.0022	CcSEcCtD
Ergonovine—Nausea—Ixabepilone—breast cancer	0.000278	0.0022	CcSEcCtD
Ergonovine—Gastrointestinal pain—Chlorambucil—breast cancer	0.000277	0.00219	CcSEcCtD
Ergonovine—Dizziness—Raloxifene—breast cancer	0.000277	0.00219	CcSEcCtD
Ergonovine—Headache—Anastrozole—breast cancer	0.000276	0.00218	CcSEcCtD
Ergonovine—Headache—Letrozole—breast cancer	0.000276	0.00218	CcSEcCtD
Ergonovine—Hypotension—Melphalan—breast cancer	0.000276	0.00218	CcSEcCtD
Ergonovine—Pergolide—CYP2D6—breast cancer	0.000276	0.14	CrCbGaD
Ergonovine—Hypertension—Vinorelbine—breast cancer	0.000273	0.00216	CcSEcCtD
Ergonovine—Hypotension—Goserelin—breast cancer	0.000269	0.00213	CcSEcCtD
Ergonovine—Chest pain—Vinorelbine—breast cancer	0.000269	0.00213	CcSEcCtD
Ergonovine—Dyspnoea—Tamoxifen—breast cancer	0.000269	0.00212	CcSEcCtD
Ergonovine—Acute coronary syndrome—Paclitaxel—breast cancer	0.000268	0.00212	CcSEcCtD
Ergonovine—Abdominal pain—Chlorambucil—breast cancer	0.000268	0.00212	CcSEcCtD
Ergonovine—Myocardial infarction—Paclitaxel—breast cancer	0.000267	0.00211	CcSEcCtD
Ergonovine—Vomiting—Raloxifene—breast cancer	0.000266	0.0021	CcSEcCtD
Ergonovine—Vomiting—Idarubicin—breast cancer	0.000266	0.0021	CcSEcCtD
Ergonovine—Pulmonary oedema—Methotrexate—breast cancer	0.000265	0.00209	CcSEcCtD
Ergonovine—Dyspnoea—Melphalan—breast cancer	0.000264	0.00208	CcSEcCtD
Ergonovine—Headache—Raloxifene—breast cancer	0.000262	0.00207	CcSEcCtD
Ergonovine—Headache—Idarubicin—breast cancer	0.000262	0.00207	CcSEcCtD
Ergonovine—Nausea—Anastrozole—breast cancer	0.000262	0.00207	CcSEcCtD
Ergonovine—Nausea—Letrozole—breast cancer	0.000262	0.00207	CcSEcCtD
Ergonovine—Hypertension—Thiotepa—breast cancer	0.000261	0.00206	CcSEcCtD
Ergonovine—Haematuria—Paclitaxel—breast cancer	0.00026	0.00205	CcSEcCtD
Ergonovine—Dyspnoea—Goserelin—breast cancer	0.000257	0.00203	CcSEcCtD
Ergonovine—Cramps of lower extremities—Epirubicin—breast cancer	0.000256	0.00202	CcSEcCtD
Ergonovine—Gastrointestinal pain—Vinblastine—breast cancer	0.000254	0.00201	CcSEcCtD
Ergonovine—Muscle spasms—Irinotecan—breast cancer	0.000251	0.00198	CcSEcCtD
Ergonovine—Thrombophlebitis—Methotrexate—breast cancer	0.000249	0.00197	CcSEcCtD
Ergonovine—Bradycardia—Paclitaxel—breast cancer	0.000249	0.00196	CcSEcCtD
Ergonovine—Nausea—Idarubicin—breast cancer	0.000249	0.00196	CcSEcCtD
Ergonovine—Nausea—Raloxifene—breast cancer	0.000249	0.00196	CcSEcCtD
Ergonovine—Pulmonary oedema—Epirubicin—breast cancer	0.000248	0.00196	CcSEcCtD
Ergonovine—Gastrointestinal pain—Tamoxifen—breast cancer	0.000247	0.00195	CcSEcCtD
Ergonovine—Abdominal pain—Vinblastine—breast cancer	0.000246	0.00194	CcSEcCtD
Ergonovine—Hypotension—Vinorelbine—breast cancer	0.000241	0.0019	CcSEcCtD
Ergonovine—Lisuride—CYP2D6—breast cancer	0.00024	0.121	CrCbGaD
Ergonovine—Abdominal pain—Tamoxifen—breast cancer	0.000239	0.00188	CcSEcCtD
Ergonovine—Pergolide—CYP3A4—breast cancer	0.000237	0.12	CrCbGaD
Ergonovine—Cramps of lower extremities—Doxorubicin—breast cancer	0.000237	0.00187	CcSEcCtD
Ergonovine—Gastrointestinal pain—Goserelin—breast cancer	0.000236	0.00186	CcSEcCtD
Ergonovine—Vertigo—Irinotecan—breast cancer	0.000234	0.00185	CcSEcCtD
Ergonovine—Thrombophlebitis—Epirubicin—breast cancer	0.000233	0.00184	CcSEcCtD
Ergonovine—Diarrhoea—Chlorambucil—breast cancer	0.000232	0.00183	CcSEcCtD
Ergonovine—Dyspnoea—Vinorelbine—breast cancer	0.00023	0.00182	CcSEcCtD
Ergonovine—Pulmonary oedema—Doxorubicin—breast cancer	0.000229	0.00181	CcSEcCtD
Ergonovine—Tinnitus—Paclitaxel—breast cancer	0.000228	0.0018	CcSEcCtD
Ergonovine—Abdominal pain—Goserelin—breast cancer	0.000228	0.0018	CcSEcCtD
Ergonovine—Acute coronary syndrome—Docetaxel—breast cancer	0.000228	0.0018	CcSEcCtD
Ergonovine—Myocardial infarction—Docetaxel—breast cancer	0.000226	0.00179	CcSEcCtD
Ergonovine—Hypertension—Mitoxantrone—breast cancer	0.000225	0.00178	CcSEcCtD
Ergonovine—Hypertension—Irinotecan—breast cancer	0.000225	0.00178	CcSEcCtD
Ergonovine—Chest pain—Mitoxantrone—breast cancer	0.000222	0.00175	CcSEcCtD
Ergonovine—Acute coronary syndrome—Capecitabine—breast cancer	0.00022	0.00174	CcSEcCtD
Ergonovine—Hypertension—Gemcitabine—breast cancer	0.000219	0.00173	CcSEcCtD
Ergonovine—Myocardial infarction—Capecitabine—breast cancer	0.000219	0.00173	CcSEcCtD
Ergonovine—Chest pain—Gemcitabine—breast cancer	0.000216	0.00171	CcSEcCtD
Ergonovine—Thrombophlebitis—Doxorubicin—breast cancer	0.000216	0.0017	CcSEcCtD
Ergonovine—Vomiting—Chlorambucil—breast cancer	0.000216	0.0017	CcSEcCtD
Ergonovine—Haematuria—Capecitabine—breast cancer	0.000213	0.00168	CcSEcCtD
Ergonovine—Chest pain—Fluorouracil—breast cancer	0.000213	0.00168	CcSEcCtD
Ergonovine—Diarrhoea—Vinblastine—breast cancer	0.000213	0.00168	CcSEcCtD
Ergonovine—Gastrointestinal pain—Vinorelbine—breast cancer	0.000211	0.00167	CcSEcCtD
Ergonovine—Shock—Mitoxantrone—breast cancer	0.00021	0.00165	CcSEcCtD
Ergonovine—Shock—Irinotecan—breast cancer	0.00021	0.00165	CcSEcCtD
Ergonovine—Diarrhoea—Tamoxifen—breast cancer	0.000207	0.00163	CcSEcCtD
Ergonovine—Hyperhidrosis—Irinotecan—breast cancer	0.000206	0.00162	CcSEcCtD
Ergonovine—Hyperhidrosis—Mitoxantrone—breast cancer	0.000206	0.00162	CcSEcCtD
Ergonovine—Dizziness—Vinblastine—breast cancer	0.000205	0.00162	CcSEcCtD
Ergonovine—Lisuride—CYP3A4—breast cancer	0.000205	0.104	CrCbGaD
Ergonovine—Muscle spasms—Paclitaxel—breast cancer	0.000205	0.00161	CcSEcCtD
Ergonovine—Bradycardia—Capecitabine—breast cancer	0.000204	0.00161	CcSEcCtD
Ergonovine—Abdominal pain—Vinorelbine—breast cancer	0.000204	0.00161	CcSEcCtD
Ergonovine—Diarrhoea—Melphalan—breast cancer	0.000202	0.0016	CcSEcCtD
Ergonovine—Gastrointestinal pain—Thiotepa—breast cancer	0.000202	0.00159	CcSEcCtD
Ergonovine—Nausea—Chlorambucil—breast cancer	0.000201	0.00159	CcSEcCtD
Ergonovine—Hyperhidrosis—Gemcitabine—breast cancer	0.000201	0.00158	CcSEcCtD
Ergonovine—Dizziness—Tamoxifen—breast cancer	0.0002	0.00158	CcSEcCtD
Ergonovine—Hypotension—Mitoxantrone—breast cancer	0.000199	0.00157	CcSEcCtD
Ergonovine—Hypotension—Irinotecan—breast cancer	0.000199	0.00157	CcSEcCtD
Ergonovine—Vomiting—Vinblastine—breast cancer	0.000198	0.00156	CcSEcCtD
Ergonovine—Ergotamine—CYP3A4—breast cancer	0.000197	0.1	CrCbGaD
Ergonovine—Diarrhoea—Goserelin—breast cancer	0.000197	0.00156	CcSEcCtD
Ergonovine—Abdominal pain—Thiotepa—breast cancer	0.000195	0.00154	CcSEcCtD
Ergonovine—Headache—Vinblastine—breast cancer	0.000195	0.00154	CcSEcCtD
Ergonovine—Hypotension—Gemcitabine—breast cancer	0.000194	0.00153	CcSEcCtD
Ergonovine—Vomiting—Tamoxifen—breast cancer	0.000192	0.00151	CcSEcCtD
Ergonovine—Vertigo—Paclitaxel—breast cancer	0.000191	0.00151	CcSEcCtD
Ergonovine—Dizziness—Goserelin—breast cancer	0.000191	0.0015	CcSEcCtD
Ergonovine—Hypotension—Fluorouracil—breast cancer	0.000191	0.0015	CcSEcCtD
Ergonovine—Bromocriptine—CYP3A4—breast cancer	0.00019	0.0964	CrCbGaD
Ergonovine—Dyspnoea—Irinotecan—breast cancer	0.00019	0.0015	CcSEcCtD
Ergonovine—Dyspnoea—Mitoxantrone—breast cancer	0.00019	0.0015	CcSEcCtD
Ergonovine—Headache—Tamoxifen—breast cancer	0.000189	0.00149	CcSEcCtD
Ergonovine—Palpitations—Paclitaxel—breast cancer	0.000188	0.00148	CcSEcCtD
Ergonovine—Vomiting—Melphalan—breast cancer	0.000188	0.00148	CcSEcCtD
Ergonovine—Tinnitus—Capecitabine—breast cancer	0.000187	0.00148	CcSEcCtD
Ergonovine—Dyspnoea—Gemcitabine—breast cancer	0.000185	0.00146	CcSEcCtD
Ergonovine—Nausea—Vinblastine—breast cancer	0.000185	0.00146	CcSEcCtD
Ergonovine—Hypertension—Paclitaxel—breast cancer	0.000184	0.00145	CcSEcCtD
Ergonovine—Vomiting—Goserelin—breast cancer	0.000183	0.00145	CcSEcCtD
Ergonovine—Dyspnoea—Fluorouracil—breast cancer	0.000182	0.00144	CcSEcCtD
Ergonovine—Chest pain—Paclitaxel—breast cancer	0.000181	0.00143	CcSEcCtD
Ergonovine—Headache—Goserelin—breast cancer	0.000181	0.00143	CcSEcCtD
Ergonovine—Nausea—Tamoxifen—breast cancer	0.000179	0.00142	CcSEcCtD
Ergonovine—Diarrhoea—Vinorelbine—breast cancer	0.000177	0.00139	CcSEcCtD
Ergonovine—Nausea—Melphalan—breast cancer	0.000176	0.00139	CcSEcCtD
Ergonovine—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000174	0.00137	CcSEcCtD
Ergonovine—Gastrointestinal pain—Irinotecan—breast cancer	0.000174	0.00137	CcSEcCtD
Ergonovine—Muscle spasms—Docetaxel—breast cancer	0.000173	0.00137	CcSEcCtD
Ergonovine—Nausea—Goserelin—breast cancer	0.000171	0.00135	CcSEcCtD
Ergonovine—Shock—Paclitaxel—breast cancer	0.000171	0.00135	CcSEcCtD
Ergonovine—Dizziness—Vinorelbine—breast cancer	0.000171	0.00135	CcSEcCtD
Ergonovine—Diarrhoea—Thiotepa—breast cancer	0.000169	0.00133	CcSEcCtD
Ergonovine—Abdominal pain—Mitoxantrone—breast cancer	0.000168	0.00133	CcSEcCtD
Ergonovine—Abdominal pain—Irinotecan—breast cancer	0.000168	0.00133	CcSEcCtD
Ergonovine—Muscle spasms—Capecitabine—breast cancer	0.000168	0.00133	CcSEcCtD
Ergonovine—Hyperhidrosis—Paclitaxel—breast cancer	0.000168	0.00133	CcSEcCtD
Ergonovine—Ergotamine—ABCB1—breast cancer	0.000164	0.0832	CrCbGaD
Ergonovine—Vomiting—Vinorelbine—breast cancer	0.000164	0.0013	CcSEcCtD
Ergonovine—Dizziness—Thiotepa—breast cancer	0.000163	0.00129	CcSEcCtD
Ergonovine—Hypotension—Paclitaxel—breast cancer	0.000162	0.00128	CcSEcCtD
Ergonovine—Headache—Vinorelbine—breast cancer	0.000162	0.00128	CcSEcCtD
Ergonovine—Sweating—Methotrexate—breast cancer	0.00016	0.00126	CcSEcCtD
Ergonovine—Palpitations—Docetaxel—breast cancer	0.000159	0.00126	CcSEcCtD
Ergonovine—Haematuria—Methotrexate—breast cancer	0.000159	0.00125	CcSEcCtD
Ergonovine—Bromocriptine—ABCB1—breast cancer	0.000158	0.0803	CrCbGaD
Ergonovine—Vertigo—Capecitabine—breast cancer	0.000157	0.00124	CcSEcCtD
Ergonovine—Vomiting—Thiotepa—breast cancer	0.000157	0.00124	CcSEcCtD
Ergonovine—Hypertension—Docetaxel—breast cancer	0.000156	0.00123	CcSEcCtD
Ergonovine—Dyspnoea—Paclitaxel—breast cancer	0.000155	0.00122	CcSEcCtD
Ergonovine—Headache—Thiotepa—breast cancer	0.000155	0.00122	CcSEcCtD
Ergonovine—Palpitations—Capecitabine—breast cancer	0.000154	0.00122	CcSEcCtD
Ergonovine—Chest pain—Docetaxel—breast cancer	0.000154	0.00121	CcSEcCtD
Ergonovine—Nausea—Vinorelbine—breast cancer	0.000153	0.00121	CcSEcCtD
Ergonovine—Hypertension—Capecitabine—breast cancer	0.000151	0.00119	CcSEcCtD
Ergonovine—Sweating—Epirubicin—breast cancer	0.000149	0.00118	CcSEcCtD
Ergonovine—Chest pain—Capecitabine—breast cancer	0.000149	0.00117	CcSEcCtD
Ergonovine—Haematuria—Epirubicin—breast cancer	0.000148	0.00117	CcSEcCtD
Ergonovine—Nausea—Thiotepa—breast cancer	0.000146	0.00116	CcSEcCtD
Ergonovine—Diarrhoea—Irinotecan—breast cancer	0.000146	0.00115	CcSEcCtD
Ergonovine—Diarrhoea—Mitoxantrone—breast cancer	0.000146	0.00115	CcSEcCtD
Ergonovine—Shock—Docetaxel—breast cancer	0.000145	0.00114	CcSEcCtD
Ergonovine—Bradycardia—Epirubicin—breast cancer	0.000142	0.00112	CcSEcCtD
Ergonovine—Gastrointestinal pain—Paclitaxel—breast cancer	0.000142	0.00112	CcSEcCtD
Ergonovine—Diarrhoea—Gemcitabine—breast cancer	0.000142	0.00112	CcSEcCtD
Ergonovine—Dizziness—Irinotecan—breast cancer	0.000141	0.00111	CcSEcCtD
Ergonovine—Shock—Capecitabine—breast cancer	0.00014	0.00111	CcSEcCtD
Ergonovine—Diarrhoea—Fluorouracil—breast cancer	0.00014	0.0011	CcSEcCtD
Ergonovine—Tinnitus—Methotrexate—breast cancer	0.000139	0.0011	CcSEcCtD
Ergonovine—Sweating—Doxorubicin—breast cancer	0.000138	0.00109	CcSEcCtD
Ergonovine—Hyperhidrosis—Capecitabine—breast cancer	0.000138	0.00109	CcSEcCtD
Ergonovine—Hypotension—Docetaxel—breast cancer	0.000138	0.00109	CcSEcCtD
Ergonovine—Haematuria—Doxorubicin—breast cancer	0.000137	0.00108	CcSEcCtD
Ergonovine—Abdominal pain—Paclitaxel—breast cancer	0.000137	0.00108	CcSEcCtD
Ergonovine—Vomiting—Mitoxantrone—breast cancer	0.000135	0.00107	CcSEcCtD
Ergonovine—Vomiting—Irinotecan—breast cancer	0.000135	0.00107	CcSEcCtD
Ergonovine—Dizziness—Fluorouracil—breast cancer	0.000135	0.00106	CcSEcCtD
Ergonovine—Headache—Irinotecan—breast cancer	0.000133	0.00105	CcSEcCtD
Ergonovine—Headache—Mitoxantrone—breast cancer	0.000133	0.00105	CcSEcCtD
Ergonovine—Hypotension—Capecitabine—breast cancer	0.000133	0.00105	CcSEcCtD
Ergonovine—Vomiting—Gemcitabine—breast cancer	0.000132	0.00104	CcSEcCtD
Ergonovine—Bradycardia—Doxorubicin—breast cancer	0.000132	0.00104	CcSEcCtD
Ergonovine—Dyspnoea—Docetaxel—breast cancer	0.000131	0.00104	CcSEcCtD
Ergonovine—Tinnitus—Epirubicin—breast cancer	0.00013	0.00103	CcSEcCtD
Ergonovine—Headache—Gemcitabine—breast cancer	0.00013	0.00103	CcSEcCtD
Ergonovine—Vomiting—Fluorouracil—breast cancer	0.00013	0.00102	CcSEcCtD
Ergonovine—Headache—Fluorouracil—breast cancer	0.000128	0.00101	CcSEcCtD
Ergonovine—Dyspnoea—Capecitabine—breast cancer	0.000127	0.001	CcSEcCtD
Ergonovine—Nausea—Irinotecan—breast cancer	0.000127	0.000998	CcSEcCtD
Ergonovine—Nausea—Mitoxantrone—breast cancer	0.000127	0.000998	CcSEcCtD
Ergonovine—Nausea—Gemcitabine—breast cancer	0.000123	0.000973	CcSEcCtD
Ergonovine—Nausea—Fluorouracil—breast cancer	0.000121	0.000956	CcSEcCtD
Ergonovine—Tinnitus—Doxorubicin—breast cancer	0.000121	0.000952	CcSEcCtD
Ergonovine—Gastrointestinal pain—Docetaxel—breast cancer	0.00012	0.00095	CcSEcCtD
Ergonovine—Diarrhoea—Paclitaxel—breast cancer	0.000119	0.000938	CcSEcCtD
Ergonovine—Muscle spasms—Epirubicin—breast cancer	0.000117	0.000923	CcSEcCtD
Ergonovine—Vertigo—Methotrexate—breast cancer	0.000117	0.000922	CcSEcCtD
Ergonovine—Gastrointestinal pain—Capecitabine—breast cancer	0.000117	0.00092	CcSEcCtD
Ergonovine—Abdominal pain—Docetaxel—breast cancer	0.000116	0.000919	CcSEcCtD
Ergonovine—Dizziness—Paclitaxel—breast cancer	0.000115	0.000907	CcSEcCtD
Ergonovine—Abdominal pain—Capecitabine—breast cancer	0.000113	0.000889	CcSEcCtD
Ergonovine—Chest pain—Methotrexate—breast cancer	0.000111	0.000874	CcSEcCtD
Ergonovine—Vomiting—Paclitaxel—breast cancer	0.00011	0.000872	CcSEcCtD
Ergonovine—Vertigo—Epirubicin—breast cancer	0.000109	0.000863	CcSEcCtD
Ergonovine—Headache—Paclitaxel—breast cancer	0.000109	0.000859	CcSEcCtD
Ergonovine—Muscle spasms—Doxorubicin—breast cancer	0.000108	0.000854	CcSEcCtD
Ergonovine—Palpitations—Epirubicin—breast cancer	0.000108	0.000849	CcSEcCtD
Ergonovine—Hypertension—Epirubicin—breast cancer	0.000105	0.000829	CcSEcCtD
Ergonovine—Chest pain—Epirubicin—breast cancer	0.000104	0.000818	CcSEcCtD
Ergonovine—Nausea—Paclitaxel—breast cancer	0.000103	0.000814	CcSEcCtD
Ergonovine—Hyperhidrosis—Methotrexate—breast cancer	0.000103	0.00081	CcSEcCtD
Ergonovine—Vertigo—Doxorubicin—breast cancer	0.000101	0.000798	CcSEcCtD
Ergonovine—Diarrhoea—Docetaxel—breast cancer	0.000101	0.000795	CcSEcCtD
Ergonovine—Palpitations—Doxorubicin—breast cancer	9.95e-05	0.000785	CcSEcCtD
Ergonovine—Hypotension—Methotrexate—breast cancer	9.92e-05	0.000783	CcSEcCtD
Ergonovine—Shock—Epirubicin—breast cancer	9.77e-05	0.000771	CcSEcCtD
Ergonovine—Diarrhoea—Capecitabine—breast cancer	9.75e-05	0.00077	CcSEcCtD
Ergonovine—Dizziness—Docetaxel—breast cancer	9.74e-05	0.000768	CcSEcCtD
Ergonovine—Hypertension—Doxorubicin—breast cancer	9.72e-05	0.000767	CcSEcCtD
Ergonovine—Hyperhidrosis—Epirubicin—breast cancer	9.6e-05	0.000758	CcSEcCtD
Ergonovine—Chest pain—Doxorubicin—breast cancer	9.59e-05	0.000756	CcSEcCtD
Ergonovine—Dyspnoea—Methotrexate—breast cancer	9.46e-05	0.000747	CcSEcCtD
Ergonovine—Dizziness—Capecitabine—breast cancer	9.43e-05	0.000744	CcSEcCtD
Ergonovine—Vomiting—Docetaxel—breast cancer	9.36e-05	0.000739	CcSEcCtD
Ergonovine—Hypotension—Epirubicin—breast cancer	9.28e-05	0.000732	CcSEcCtD
Ergonovine—Headache—Docetaxel—breast cancer	9.22e-05	0.000728	CcSEcCtD
Ergonovine—Vomiting—Capecitabine—breast cancer	9.06e-05	0.000715	CcSEcCtD
Ergonovine—Shock—Doxorubicin—breast cancer	9.04e-05	0.000713	CcSEcCtD
Ergonovine—Headache—Capecitabine—breast cancer	8.93e-05	0.000705	CcSEcCtD
Ergonovine—Hyperhidrosis—Doxorubicin—breast cancer	8.88e-05	0.000701	CcSEcCtD
Ergonovine—Dyspnoea—Epirubicin—breast cancer	8.85e-05	0.000699	CcSEcCtD
Ergonovine—Nausea—Docetaxel—breast cancer	8.75e-05	0.00069	CcSEcCtD
Ergonovine—Gastrointestinal pain—Methotrexate—breast cancer	8.68e-05	0.000685	CcSEcCtD
Ergonovine—Hypotension—Doxorubicin—breast cancer	8.59e-05	0.000678	CcSEcCtD
Ergonovine—Nausea—Capecitabine—breast cancer	8.47e-05	0.000668	CcSEcCtD
Ergonovine—Abdominal pain—Methotrexate—breast cancer	8.39e-05	0.000662	CcSEcCtD
Ergonovine—Dyspnoea—Doxorubicin—breast cancer	8.19e-05	0.000647	CcSEcCtD
Ergonovine—Gastrointestinal pain—Epirubicin—breast cancer	8.12e-05	0.000641	CcSEcCtD
Ergonovine—Abdominal pain—Epirubicin—breast cancer	7.85e-05	0.00062	CcSEcCtD
Ergonovine—Gastrointestinal pain—Doxorubicin—breast cancer	7.51e-05	0.000593	CcSEcCtD
Ergonovine—Abdominal pain—Doxorubicin—breast cancer	7.26e-05	0.000573	CcSEcCtD
Ergonovine—Diarrhoea—Methotrexate—breast cancer	7.26e-05	0.000573	CcSEcCtD
Ergonovine—Dizziness—Methotrexate—breast cancer	7.02e-05	0.000554	CcSEcCtD
Ergonovine—Diarrhoea—Epirubicin—breast cancer	6.79e-05	0.000536	CcSEcCtD
Ergonovine—Vomiting—Methotrexate—breast cancer	6.75e-05	0.000532	CcSEcCtD
Ergonovine—Headache—Methotrexate—breast cancer	6.65e-05	0.000525	CcSEcCtD
Ergonovine—Dizziness—Epirubicin—breast cancer	6.57e-05	0.000518	CcSEcCtD
Ergonovine—Vomiting—Epirubicin—breast cancer	6.31e-05	0.000498	CcSEcCtD
Ergonovine—Nausea—Methotrexate—breast cancer	6.3e-05	0.000497	CcSEcCtD
Ergonovine—Diarrhoea—Doxorubicin—breast cancer	6.29e-05	0.000496	CcSEcCtD
Ergonovine—Headache—Epirubicin—breast cancer	6.22e-05	0.000491	CcSEcCtD
Ergonovine—Dizziness—Doxorubicin—breast cancer	6.08e-05	0.00048	CcSEcCtD
Ergonovine—Nausea—Epirubicin—breast cancer	5.9e-05	0.000466	CcSEcCtD
Ergonovine—Vomiting—Doxorubicin—breast cancer	5.84e-05	0.000461	CcSEcCtD
Ergonovine—Headache—Doxorubicin—breast cancer	5.76e-05	0.000454	CcSEcCtD
Ergonovine—Nausea—Doxorubicin—breast cancer	5.46e-05	0.000431	CcSEcCtD
Ergonovine—ADRA1A—Signaling Pathways—ITPR1—breast cancer	7.37e-06	0.00013	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—SRC—breast cancer	7.34e-06	0.000129	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ERBB4—breast cancer	7.32e-06	0.000129	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STAT5A—breast cancer	7.32e-06	0.000129	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MMP3—breast cancer	7.32e-06	0.000129	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CB—breast cancer	7.3e-06	0.000128	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	7.28e-06	0.000128	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—FASN—breast cancer	7.26e-06	0.000128	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—BCHE—breast cancer	7.23e-06	0.000127	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL2—breast cancer	7.16e-06	0.000126	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—VEGFA—breast cancer	7.15e-06	0.000126	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SLC5A5—breast cancer	7.14e-06	0.000126	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TERT—breast cancer	7.13e-06	0.000126	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTA4—breast cancer	7.1e-06	0.000125	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CA9—breast cancer	7.1e-06	0.000125	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SMAD4—breast cancer	7.09e-06	0.000125	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—STAT3—breast cancer	7.07e-06	0.000124	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IGF1R—breast cancer	7.05e-06	0.000124	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCL8—breast cancer	7.01e-06	0.000123	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FGFR1—breast cancer	6.93e-06	0.000122	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HES1—breast cancer	6.92e-06	0.000122	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTA2—breast cancer	6.91e-06	0.000122	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GPX2—breast cancer	6.91e-06	0.000122	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NQO1—breast cancer	6.9e-06	0.000121	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SLC2A1—breast cancer	6.9e-06	0.000121	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NCOR1—breast cancer	6.88e-06	0.000121	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PLA2G4A—breast cancer	6.88e-06	0.000121	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GPX4—breast cancer	6.83e-06	0.00012	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SULT1A1—breast cancer	6.83e-06	0.00012	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HIF1A—breast cancer	6.82e-06	0.00012	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGF1—breast cancer	6.81e-06	0.00012	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CSF2—breast cancer	6.81e-06	0.00012	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—RAF1—breast cancer	6.79e-06	0.000119	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MAPK3—breast cancer	6.76e-06	0.000119	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NRG1—breast cancer	6.76e-06	0.000119	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP3A4—breast cancer	6.73e-06	0.000118	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—H2AFX—breast cancer	6.71e-06	0.000118	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—IL2—breast cancer	6.7e-06	0.000118	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTA1—breast cancer	6.67e-06	0.000117	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—IDH1—breast cancer	6.67e-06	0.000117	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—E2F1—breast cancer	6.66e-06	0.000117	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LEP—breast cancer	6.66e-06	0.000117	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CB—breast cancer	6.63e-06	0.000117	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP1B1—breast cancer	6.61e-06	0.000116	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CAV1—breast cancer	6.6e-06	0.000116	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NAT2—breast cancer	6.6e-06	0.000116	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	6.58e-06	0.000116	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MYC—breast cancer	6.57e-06	0.000116	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TGFB1—breast cancer	6.56e-06	0.000115	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KDR—breast cancer	6.52e-06	0.000115	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HSP90AA1—breast cancer	6.49e-06	0.000114	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—EGFR—breast cancer	6.43e-06	0.000113	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SPP1—breast cancer	6.4e-06	0.000113	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCL8—breast cancer	6.37e-06	0.000112	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ESR1—breast cancer	6.36e-06	0.000112	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ERBB3—breast cancer	6.33e-06	0.000111	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGFR2—breast cancer	6.32e-06	0.000111	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NCOA1—breast cancer	6.31e-06	0.000111	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FN1—breast cancer	6.28e-06	0.000111	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—STK11—breast cancer	6.22e-06	0.000109	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP19A1—breast cancer	6.22e-06	0.000109	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NFKBIA—breast cancer	6.21e-06	0.000109	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NOTCH1—breast cancer	6.15e-06	0.000108	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL2—breast cancer	6.09e-06	0.000107	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—KRAS—breast cancer	6.07e-06	0.000107	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TERT—breast cancer	6.07e-06	0.000107	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CG—breast cancer	6.01e-06	0.000106	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KIT—breast cancer	6.01e-06	0.000106	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APC—breast cancer	6.01e-06	0.000106	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EGF—breast cancer	5.94e-06	0.000105	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGFR1—breast cancer	5.89e-06	0.000104	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HIF1A—breast cancer	5.8e-06	0.000102	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MED12—breast cancer	5.78e-06	0.000102	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—DPYD—breast cancer	5.78e-06	0.000102	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—COMT—breast cancer	5.78e-06	0.000102	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—MAPK3—breast cancer	5.76e-06	0.000101	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTP1—breast cancer	5.75e-06	0.000101	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALDOA—breast cancer	5.69e-06	0.0001	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HMOX1—breast cancer	5.68e-06	9.99e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LEP—breast cancer	5.66e-06	9.96e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ITPR1—breast cancer	5.66e-06	9.96e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—BRAF—breast cancer	5.65e-06	9.94e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CAV1—breast cancer	5.61e-06	9.87e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PIK3CA—breast cancer	5.58e-06	9.82e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KDR—breast cancer	5.55e-06	9.76e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NCOA3—breast cancer	5.53e-06	9.73e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IGF1—breast cancer	5.5e-06	9.68e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AKT2—breast cancer	5.5e-06	9.68e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC2A2—breast cancer	5.49e-06	9.66e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—EGFR—breast cancer	5.48e-06	9.64e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ESR1—breast cancer	5.41e-06	9.51e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TP53—breast cancer	5.4e-06	9.5e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MTR—breast cancer	5.38e-06	9.46e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ABCG2—breast cancer	5.38e-06	9.46e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CPT1A—breast cancer	5.38e-06	9.46e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—TYMS—breast cancer	5.35e-06	9.41e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FN1—breast cancer	5.34e-06	9.4e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NCOR1—breast cancer	5.29e-06	9.31e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTM1—breast cancer	5.29e-06	9.31e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PLA2G4A—breast cancer	5.29e-06	9.31e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CD—breast cancer	5.28e-06	9.3e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NFKBIA—breast cancer	5.28e-06	9.29e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HPGDS—breast cancer	5.27e-06	9.28e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HBA1—breast cancer	5.24e-06	9.22e-05	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PIK3CA—breast cancer	5.23e-06	9.21e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NOTCH1—breast cancer	5.23e-06	9.2e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SERPINE1—breast cancer	5.23e-06	9.2e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—KRAS—breast cancer	5.17e-06	9.1e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—HRAS—breast cancer	5.16e-06	9.09e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ACHE—breast cancer	5.12e-06	9e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTT1—breast cancer	5.12e-06	9e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APC—breast cancer	5.11e-06	8.99e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KIT—breast cancer	5.11e-06	8.99e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CG—breast cancer	5.11e-06	8.99e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GPX1—breast cancer	5.06e-06	8.91e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EGF—breast cancer	5.05e-06	8.89e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP1A1—breast cancer	5.01e-06	8.82e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NOS3—breast cancer	4.99e-06	8.78e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ERCC2—breast cancer	4.97e-06	8.75e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL6—breast cancer	4.94e-06	8.7e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—MAPK3—breast cancer	4.89e-06	8.61e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP17A1—breast cancer	4.84e-06	8.52e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—BRAF—breast cancer	4.8e-06	8.45e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PTGS1—breast cancer	4.79e-06	8.43e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ENO1—breast cancer	4.79e-06	8.43e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3CA—breast cancer	4.75e-06	8.36e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MDM2—breast cancer	4.73e-06	8.33e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RAF1—breast cancer	4.72e-06	8.3e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP2D6—breast cancer	4.7e-06	8.27e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RELA—breast cancer	4.7e-06	8.26e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IGF1—breast cancer	4.68e-06	8.23e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AKT2—breast cancer	4.68e-06	8.23e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—MTHFR—breast cancer	4.67e-06	8.22e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ERBB2—breast cancer	4.67e-06	8.21e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—EGFR—breast cancer	4.66e-06	8.19e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NCOA2—breast cancer	4.61e-06	8.12e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CB—breast cancer	4.61e-06	8.1e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MTOR—breast cancer	4.61e-06	8.1e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—AKT1—breast cancer	4.56e-06	8.02e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CD—breast cancer	4.49e-06	7.91e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—FASN—breast cancer	4.47e-06	7.87e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—BCHE—breast cancer	4.46e-06	7.84e-05	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CA—breast cancer	4.45e-06	7.83e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SERPINE1—breast cancer	4.44e-06	7.82e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCL8—breast cancer	4.43e-06	7.79e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC5A5—breast cancer	4.4e-06	7.75e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—KRAS—breast cancer	4.4e-06	7.74e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—HRAS—breast cancer	4.4e-06	7.74e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CDKN1B—breast cancer	4.32e-06	7.61e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CAV1—breast cancer	4.31e-06	7.59e-05	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—AKT1—breast cancer	4.28e-06	7.52e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NQO1—breast cancer	4.25e-06	7.48e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC2A1—breast cancer	4.25e-06	7.48e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NOS3—breast cancer	4.24e-06	7.46e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CASP3—breast cancer	4.24e-06	7.45e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL2—breast cancer	4.23e-06	7.44e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL6—breast cancer	4.21e-06	7.41e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCND1—breast cancer	4.12e-06	7.26e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—JUN—breast cancer	4.11e-06	7.24e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CTNNB1—breast cancer	4.08e-06	7.18e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP1B1—breast cancer	4.08e-06	7.17e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	4.04e-06	7.11e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MDM2—breast cancer	4.02e-06	7.08e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RAF1—breast cancer	4.01e-06	7.06e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MMP9—breast cancer	4e-06	7.04e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HSP90AA1—breast cancer	4e-06	7.03e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RELA—breast cancer	3.99e-06	7.03e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CDKN1A—breast cancer	3.99e-06	7.02e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTEN—breast cancer	3.98e-06	7e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ERBB2—breast cancer	3.97e-06	6.98e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CG—breast cancer	3.93e-06	6.91e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	3.92e-06	6.89e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MTOR—breast cancer	3.92e-06	6.89e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAPK8—breast cancer	3.89e-06	6.85e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NCOA1—breast cancer	3.89e-06	6.84e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—AKT1—breast cancer	3.88e-06	6.83e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP19A1—breast cancer	3.83e-06	6.74e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—STK11—breast cancer	3.83e-06	6.74e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCL8—breast cancer	3.76e-06	6.62e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—HRAS—breast cancer	3.74e-06	6.58e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SRC—breast cancer	3.69e-06	6.49e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	3.67e-06	6.47e-05	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	3.64e-06	6.4e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CASP3—breast cancer	3.6e-06	6.34e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL2—breast cancer	3.6e-06	6.33e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—VEGFA—breast cancer	3.59e-06	6.32e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6—breast cancer	3.58e-06	6.3e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—COMT—breast cancer	3.56e-06	6.27e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—STAT3—breast cancer	3.56e-06	6.26e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTP1—breast cancer	3.55e-06	6.24e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCND1—breast cancer	3.51e-06	6.17e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—JUN—breast cancer	3.5e-06	6.16e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HMOX1—breast cancer	3.5e-06	6.15e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ITPR1—breast cancer	3.49e-06	6.14e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	3.47e-06	6.11e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CD—breast cancer	3.45e-06	6.07e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ALB—breast cancer	3.41e-06	6e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MMP9—breast cancer	3.4e-06	5.99e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAPK3—breast cancer	3.4e-06	5.98e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	3.39e-06	5.97e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTEN—breast cancer	3.38e-06	5.95e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ABCB1—breast cancer	3.36e-06	5.91e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	3.31e-06	5.82e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MYC—breast cancer	3.31e-06	5.82e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	3.3e-06	5.81e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TGFB1—breast cancer	3.3e-06	5.81e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—TYMS—breast cancer	3.3e-06	5.8e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NOS3—breast cancer	3.26e-06	5.74e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NCOR1—breast cancer	3.26e-06	5.73e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTM1—breast cancer	3.26e-06	5.73e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.26e-06	5.73e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EGFR—breast cancer	3.23e-06	5.69e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SRC—breast cancer	3.14e-06	5.52e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GPX1—breast cancer	3.12e-06	5.49e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP1A1—breast cancer	3.09e-06	5.43e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ERCC2—breast cancer	3.06e-06	5.39e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	3.06e-06	5.38e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KRAS—breast cancer	3.06e-06	5.38e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STAT3—breast cancer	3.03e-06	5.33e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CB—breast cancer	3.01e-06	5.29e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PTGS2—breast cancer	2.98e-06	5.25e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	2.89e-06	5.09e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MTHFR—breast cancer	2.88e-06	5.07e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MYC—breast cancer	2.81e-06	4.95e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	2.81e-06	4.94e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	2.81e-06	4.94e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EGFR—breast cancer	2.75e-06	4.84e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TP53—breast cancer	2.72e-06	4.78e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CAV1—breast cancer	2.66e-06	4.67e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PTEN—breast cancer	2.6e-06	4.58e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KRAS—breast cancer	2.6e-06	4.57e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HRAS—breast cancer	2.6e-06	4.57e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6—breast cancer	2.49e-06	4.37e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CG—breast cancer	2.42e-06	4.26e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	2.39e-06	4.2e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TP53—breast cancer	2.31e-06	4.06e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AKT1—breast cancer	2.29e-06	4.04e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HRAS—breast cancer	2.21e-06	3.89e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CD—breast cancer	2.13e-06	3.74e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6—breast cancer	2.11e-06	3.72e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALB—breast cancer	2.1e-06	3.69e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NOS3—breast cancer	2.01e-06	3.53e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AKT1—breast cancer	1.95e-06	3.43e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.85e-06	3.26e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PTGS2—breast cancer	1.84e-06	3.23e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CA—breast cancer	1.83e-06	3.23e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PTEN—breast cancer	1.6e-06	2.82e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AKT1—breast cancer	1.5e-06	2.64e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CA—breast cancer	1.13e-06	1.99e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AKT1—breast cancer	9.23e-07	1.62e-05	CbGpPWpGaD
